MedTrace Logo

SMS Maama Project COVID-19

NCT04739462 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 248

Last updated 2022-04-14

No results posted yet for this study

Summary

The study's purpose is to demonstrate the ability of an mHealth platform as a feasible way of sharing information in a time of restricted movement in order to inform future studies.

Conditions

  • Pregnancy Complications
  • Birth Injuries

Interventions

BEHAVIORAL

mHealth Platform

All participants randomized to the intervention group will receive 2-4 informational texts each week and will also receive interactive health screening questions throughout enrollment. A participant will also receive appointment reminder texts. All SMS text messages will be transmitted through a local organization known as The Medical Concierge Group (TMCG) via an electronic system that allows for bulk messaging. TMCG also staffs a 24-hour call line for those using TMCG services to call in for medical related questions. This call line is staffed by doctors and nurses; SMS Maama participants randomized to the interventional group will be able to access this call line free of charge as part of their enrollment in SMS Maama.

Sponsors & Collaborators

Principal Investigators

  • Betty Nakabuye, MBChB, MMed · Lubaga Hospital and School of Public Health, Makerere University

  • Jolly Beyeza · Mulago Specialised Women's Hospital and School of Medicine, Makerere University

  • Katelyn Pastick · University of Minnesota

  • Cheryl Robertson · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-28
Primary Completion
2021-10-21
Completion
2021-10-21

Countries

  • United States
  • Uganda

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04739462 on ClinicalTrials.gov